Medical Condition News

RSS

Telormedix completes Phase II trial of Vesimune in CIS of the bladder

Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, today announced that it has successfully completed a Phase II trial, conducted under an IND, of Vesimune (TMX-101) in CIS (carcinoma in situ) of the bladder.

16 May 2014

Sleep-breathing disorder diminishes activity among neurons responsible for keeping heart rate low

Sufferers of a common sleep-breathing disorder have diminished activity among neurons responsible for keeping heart rate low, reveals a new study published today [16 May] in The Journal of Physiology.

16 May 2014

Research shows sugar has direct effect on cardiovascular risk-factors independent of weight gain

Researchers from New Zealand's University of Otago have uncovered evidence that sugar has a direct effect on risk factors for heart disease, and is likely to impact on blood pressure, independent of weight gain.

16 May 2014

Fathers who work in engineering are two times as likely to have child with ASD

Children of fathers who are in technical occupations are more likely to have an autism spectrum disorder, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).

16 May 2014

Researchers examine how basic biology of aging drives chronic disease

A new collection of articles appearing in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences examine how the basic biology of aging drives chronic disease.

16 May 2014

St. Jude analysis reveals how protein p53 triggers cancer cells to commit suicide

St. Jude Children's Research Hospital scientists have mapped the structural details of how p53 attaches to its regulatory protein, called BCL-xL, in the cell.

16 May 2014

New intervention program may benefit chronically homeless, alcohol-dependent individuals

Chronically homeless, alcohol-dependent individuals might benefit from a new intervention that does not require them to stop or even reduce drinking, according to the results of a preliminary study in Seattle.

16 May 2014

Young adults who smoke water pipes have elevated levels of tobacco-related cancer-causing agents

Young adults who smoked water pipes in hookah bars had elevated levels of nicotine, cotinine, tobacco-related cancer-causing agents, and volatile organic compounds (VOC) in their urine, and this may increase their risk for cancer and other chronic diseases, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

16 May 2014

Meditation training may help reduce stress disorders among US military personnel

Researchers from the University of California, San Diego School of Medicine and Naval Health Research Center have found that mindfulness training - a combination of meditation and body awareness exercises - can help U.S. Marine Corps personnel prepare for and recover from stressful combat situations.

16 May 2014

CVD risk factors may differ between men and women with type 2 diabetes, shows study

Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

16 May 2014

Researchers develop potential route to new therapies for treatment of Parkinson's disease

A biologist and a psychologist at the University of York have joined forces with a drug discovery group at Lundbeck in Denmark to develop a potential route to new therapies for the treatment of Parkinson's Disease (PD).

16 May 2014

Young adult social drinkers may develop alcohol use disorder over time

Heavy social drinkers who report greater stimulation and reward from alcohol are more likely to develop alcohol use disorder over time, report researchers from the University of Chicago, May 15 in the journal Biological Psychiatry.

16 May 2014

Loyola’s Gastrointestinal Cancer Risk Assessment Program provides state-of-the-art care to cancer patients

Patients at increased risk for gastrointestinal cancer now have access to a new multidisciplinary program at Loyola University Health System.

16 May 2014

Link found between antibiotic use in babies and asthma

New research has shed light on how treating babies with antibiotics may lead to an increased risk for asthma.

15 May 2014

Actavis reaches agreement to continue supplying authorized generic version of JPI's Concerta

Actavis plc today announced that it has reached an agreement with Janssen Pharmaceuticals, Inc. to continue supplying the authorized generic version of JPI's Concerta (methylphenidate hydrochloride extended-release tablets).

15 May 2014

Inspire Medical Systems completes $40 million Series E financing

Inspire Medical Systems, Inc. announced today that it has completed a Series E financing of $40 million. The financing round was strategically timed to coincide with the commercial launch of the Inspire Upper Airway Stimulation (UAS) therapy in the United States.

15 May 2014

BRF expands study to evaluate whether structured exercise slows progression of AD

The Brain Research Foundation (BRF) today announced that it will provide a major grant that will further research funded by the National Institute of Aging (NIA) which evaluated whether structured exercise slows the progression of Alzheimer's disease.

15 May 2014

Researchers recommend greater emphasis on cardiology in HIV treatment and research

Even if treated, hypertension and high cholesterol are increasingly common for people with human immunodeficiency virus (HIV), according to a new study from researchers at Mount Sinai St. Luke's and Mount Sinai Roosevelt hospitals in New York and the University of California, Davis.

15 May 2014

Transition Therapeutics begins TT-401 Phase 2 clinical study for treatment of type 2 diabetes

Transition Therapeutics Inc. today announced the dosing of the first patient in a Phase 2 clinical study of TT-401 (LY2944876), a drug candidate for the treatment of type 2 diabetes.

15 May 2014

Promedior to present interim data from PRM-151 Phase 2 trial at ASCO 2014 Annual Meeting

Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that principal investigator, Srdan Verstovsek, MD, PhD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 2, 2014 at the American Society for Clinical Oncology 2014 Annual Meeting.

15 May 2014

Medical Condition News

Telormedix completes Phase II trial of Vesimune in CIS of the bladder

Sleep-breathing disorder diminishes activity among neurons responsible for keeping heart rate low

Research shows sugar has direct effect on cardiovascular risk-factors independent of weight gain

Fathers who work in engineering are two times as likely to have child with ASD

Researchers examine how basic biology of aging drives chronic disease

St. Jude analysis reveals how protein p53 triggers cancer cells to commit suicide

New intervention program may benefit chronically homeless, alcohol-dependent individuals

Young adults who smoke water pipes have elevated levels of tobacco-related cancer-causing agents

Meditation training may help reduce stress disorders among US military personnel

CVD risk factors may differ between men and women with type 2 diabetes, shows study

Researchers develop potential route to new therapies for treatment of Parkinson's disease

Young adult social drinkers may develop alcohol use disorder over time

Loyola’s Gastrointestinal Cancer Risk Assessment Program provides state-of-the-art care to cancer patients

Link found between antibiotic use in babies and asthma

Actavis reaches agreement to continue supplying authorized generic version of JPI's Concerta

Inspire Medical Systems completes $40 million Series E financing

BRF expands study to evaluate whether structured exercise slows progression of AD

Researchers recommend greater emphasis on cardiology in HIV treatment and research

Transition Therapeutics begins TT-401 Phase 2 clinical study for treatment of type 2 diabetes

Promedior to present interim data from PRM-151 Phase 2 trial at ASCO 2014 Annual Meeting

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News